Organization: Health Canada
Year: 2022
Month: January
Request Number: A-2020-001875
Request Summary: Adverse Drug Reactions (ADRs) for Dexilant. Report numbers: E2B_03438771, E2B_03406729, E2B_03478199, 929730, E2B_03450952, E2B_03409017, E2B_03480836, E2B_03452280. ADR for Dexlansoprazole. Report number: E2B_03478048. ADRs for Entyvio. Report numbers: E2B_03424448, E2B_03503241, 927145.
Disposition: Disclosed in part
Number of pages: 327